Kameel D. Farag

Companies

• BIOVIE INC.Board member Oct 28, 2025 to now¹
• Akari Therapeutics PlcChief financial officer Oct 24, 2025 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAkari Therapeutics Plc AKTX23,309 shares³$195.1K at $8.37Aug 17, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 17, 2026Granted 1,728 shares at $7.52 of Akari Therapeutics Plc³
• Jul 16, 2026Granted 1,130 shares at $11.50 of Akari Therapeutics Plc⁴
• Jun 24, 2026Granted 1,000 shares at $13.00 of Akari Therapeutics Plc⁵
• Jun 24, 2026Granted 7,353 shares at $3.74 of Akari Therapeutics Plc⁵
• Jun 24, 2026Granted 3,725 shares at $3.49 of Akari Therapeutics Plc⁵
• Jun 24, 2026Granted 2,539 shares at $5.12 of Akari Therapeutics Plc⁵
• Jun 24, 2026Granted 1,570 shares at $8.28 of Akari Therapeutics Plc⁵
• Jun 24, 2026Granted 1,395 shares at $9.32 of Akari Therapeutics Plc⁵
• Jun 24, 2026Granted 1,248 shares at $10.02 of Akari Therapeutics Plc⁵
• Nov 1, 2025Granted 26,619 shares at $0.75 of Akari Therapeutics Plc⁶
• Nov 1, 2025Granted 32,000 shares at $0.75 of Akari Therapeutics Plc⁶
• Oct 22, 2025Granted 6,277 shares at $0.74 of Akari Therapeutics Plc⁷